Medicare Enrolled

Dr. Sherwin Yen, MD

Student in an Organized Health Care Education/Training Program · Austin, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
12221 N MOPAC EXPY, Austin, TX 78758
5129014005
In practice since 2009 (16 years)
NPI: 1720212426 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yen? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yen

Dr. Sherwin Yen is a student in an organized health care education/training program specialist in Austin, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Yen performed 7,107 Medicare services across 2,316 unique beneficiaries.

Between the years covered by Open Payments, Dr. Yen received a total of $8,854 from 33 pharmaceutical and/or device companies across 197 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yen is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 2% volume in TX $8,854 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,107
Medicare services
Top 2% in TX for student in an organized health care education/training program
2,316
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~444 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 3,540 $19 $44
Office visit, established patient (30-39 min) 506 $90 $206
Blood draw (venipuncture) 436 $8 $9
Comprehensive metabolic blood panel 382 $10 $45
Thyroid stimulating hormone (TSH) test 280 $16 $71
Hemoglobin A1c test (diabetes monitoring) 266 $9 $41
Lipid panel (cholesterol and triglycerides) 265 $13 $57
Free thyroxine (T4) test 242 $9 $39
Urine microalbumin test (kidney screening) 215 $6 $24
Creatinine test (kidney function) 214 $5 $22
Vitamin D level test 122 $29 $115
Office visit, established patient (20-29 min) 110 $64 $139
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 102 $25 $127
Parathyroid hormone level test 92 $40 $175
Drug injection, under skin or into muscle 85 $12 $70
New patient office visit (45-59 min) 34 $113 $320
Testosterone (hormone) level, total 29 $22 $109
Sex hormone binding globulin (protein) level 28 $18 $92
Thyroid hormone, t3 measurement, free 28 $16 $72
New patient office visit (30-44 min) 25 $84 $208
Measurement of total estradiol (hormone) 24 $24 $118
Complete blood count (CBC) with differential 23 $8 $33
Prolactin (milk producing hormone) level 18 $19 $82
Protein measurement, serum 18 $11 $46
Telephone medical discussion with physician, 11-20 minutes 12 $73 $152
Gonadotropin, luteinizing (reproductive hormone) level 11 $18 $79
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,854
Total received (2018-2024)
Avg $1,265/year across 7 years
Top 5% in TX for student in an organized health care education/training program
33
Companies
197
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,589 (51.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,265 (48.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,063
2023
$817
2022
$238
2021
$264
2020
$292
2019
$1,621
2018
$4,560

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$5,165
Tandem Diabetes Care, Inc.
$883
Lilly USA, LLC
$497
Abbott Laboratories
$425
Amgen Inc.
$312
Dexcom, Inc.
$243
SANOFI-AVENTIS U.S. LLC
$185
Bayer Healthcare Pharmaceuticals Inc.
$122
Insulet Corporation
$113
CeQur Corporation
$108
Corindus Inc.
$107
Boehringer Ingelheim Pharmaceuticals, Inc.
$79
Medtronic, Inc.
$66
Mannkind Corporation
$59
Rhythm Pharmaceuticals, Inc.
$58
Radius Health, Inc.
$49
DEXCOM, INC.
$36
Becton, Dickinson and Company
$33
Xeris Pharmaceuticals, Inc.
$31
AbbVie Inc.
$30
Amneal Pharmaceuticals LLC
$27
IBSA Pharma Inc.
$27
BETA BIONICS, INC.
$26
MannKind Corporation
$24
ABBVIE INC.
$22
Ascensia Diabetes Care Us Inc.
$21
Amarin Pharma Inc.
$19
Valeritas, Inc.
$18
LifeScan, Inc.
$17
AstraZeneca Pharmaceuticals LP
$14
Corcept Therapeutics
$13
VistaPharm, Inc.
$12
Horizon Therapeutics plc
$11
Top 3 companies account for 73.9% of total payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD Nano · CeQur Simplicity · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GVOKE HYPOPEN · HUMULIN · HUMULIN R 500 · IMCIVREE · JARDIANCE · Kerendia · Korlym · LOKELMA · MINIMED 770G · MINIMED 780G · MOUNJARO · OT Verio Flex Starter Kit · Omnipod · Ozempic · Repatha · Rybelsus · SOLIQUA 100/33 · SYNJARDY XR · SYNTHROID · Saxenda · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Victoza · Wegovy · ZEPBOUND · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (52%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for student in an organized health care education/training program in TX.

Equivalent to $125 per 100 Medicare services performed
Looking for a student in an organized health care education/training program specialist in Austin?
Compare student in an organized health care education/training programs in the Austin area by procedure volume, costs, and industry payment transparency.
Browse student in an organized health care education/training programs nearby

Geographic Context

Student in an organized health care education/training programs within 10 mi
791
Per 100K population
60.5
County median income
$97,169
Nearest hospital
NORTH AUSTIN MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Yen is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), with low-engagement industry engagement in the top 5% of TX peers, with 16 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Yen experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Yen performed 3,540 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yen receive payments from pharmaceutical companies?
Yes. Dr. Yen received a total of $8,854 from 33 companies across 197 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yen's costs compare to other student in an organized health care education/training programs in Austin?
Dr. Yen's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →